Combination of a chemotherapeutic agent and an antagonist of a gene product for treating tumors

Details for Australian Patent Application No. 2005265067 (hide)

Owner Genentech, Inc.

Inventors Polakis, Paul

Agent Griffith Hack

Pub. Number AU-B-2005265067

PCT Pub. Number WO2006/009805

Priority 60/580,745 18.06.04 US

Filing date 17 June 2005

Wipo publication date 26 January 2006

Acceptance publication date 16 December 2010

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/4745 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/009805 Priority application(s): WO2006/009805

16 December 2010 Application Accepted

  Published as AU-B-2005265067

14 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005265068-Composite closure with barrier end panel

2005265057-Method and apparatus for retaining screws in a plate